(Reuters) - Merck & Co Inc said on Monday that health regulators are concerned about operational aspects of a hypersensitivity study for sugammadex, an injection designed to reverse the effects of muscle relaxants used by anesthesiologists during surgery.
via Reuters: Health News Read More Here..
No comments:
Post a Comment